News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
784,911 Results
Type
Article (79945)
Company Profile (375)
Press Release (704570)
Multimedia
Podcasts (149)
Webinars (23)
Section
Business (206847)
Career Advice (3496)
Deals (37616)
Drug Delivery (132)
Drug Development (88298)
Employer Resources (189)
FDA (17818)
Job Trends (16421)
News (363295)
Policy (37960)
Tag
Academia (2993)
Academic (1)
Accelerated approval (17)
Adcomms (33)
Allergies (116)
Alliances (52749)
ALS (134)
Alzheimer's disease (1636)
Antibody-drug conjugate (ADC) (201)
Approvals (17803)
Artificial intelligence (413)
Autoimmune disease (41)
Automation (23)
Bankruptcy (383)
Best Places to Work (12428)
BIOSECURE Act (22)
Biosimilars (145)
Biotechnology (255)
Bladder cancer (116)
Brain cancer (45)
Breast cancer (426)
Cancer (3453)
Cardiovascular disease (303)
Career advice (2974)
Career pathing (36)
CAR-T (225)
CDC (45)
Cell therapy (601)
Cervical cancer (29)
Clinical research (72678)
Collaboration (1253)
Company closure (4)
Compensation (844)
Complete response letters (48)
COVID-19 (2933)
CRISPR (75)
C-suite (480)
Cystic fibrosis (127)
Data (3648)
Decentralized trials (2)
Denatured (47)
Depression (91)
Diabetes (406)
Diagnostics (6937)
Digital health (27)
Diversity (10)
Diversity, equity & inclusion (45)
Drug discovery (185)
Drug pricing (166)
Drug shortages (36)
Duchenne muscular dystrophy (179)
Earnings (82029)
Editorial (52)
Employer branding (25)
Employer resources (163)
Events (117461)
Executive appointments (946)
FDA (19993)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1102)
Gene editing (161)
Generative AI (31)
Gene therapy (481)
GLP-1 (981)
Government (5248)
Grass and pollen (7)
Guidances (330)
Healthcare (20713)
HIV (46)
Huntington's disease (32)
IgA nephropathy (52)
Immunology and inflammation (208)
Immuno-oncology (17)
Indications (45)
Infectious disease (3147)
Inflammatory bowel disease (177)
Inflation Reduction Act (12)
Influenza (85)
Intellectual property (156)
Interviews (665)
IPO (17505)
IRA (58)
Job creations (4404)
Job search strategy (2432)
Kidney cancer (14)
Labor market (62)
Layoffs (618)
Leadership (30)
Legal (9430)
Liver cancer (88)
Longevity (12)
Lung cancer (500)
Lymphoma (250)
Machine learning (21)
Management (64)
Manufacturing (532)
MASH (115)
Medical device (14624)
Medtech (14641)
Mergers & acquisitions (20939)
Metabolic disorders (1044)
Multiple sclerosis (115)
NASH (23)
Neurodegenerative disease (174)
Neuropsychiatric disorders (48)
Neuroscience (2500)
NextGen: Class of 2025 (7417)
Non-profit (5051)
Now hiring (51)
Obesity (528)
Opinion (301)
Ovarian cancer (112)
Pain (149)
Pancreatic cancer (142)
Parkinson's disease (210)
Partnered (26)
Patents (377)
Patient recruitment (251)
Peanut (56)
People (61799)
Pharmaceutical (83)
Pharmacy benefit managers (25)
Phase I (22269)
Phase II (31632)
Phase III (23905)
Pipeline (2408)
Policy (273)
Postmarket research (3373)
Preclinical (9886)
Press Release (69)
Prostate cancer (167)
Psychedelics (49)
Radiopharmaceuticals (274)
Rare diseases (586)
Real estate (6665)
Recruiting (76)
Regulatory (26495)
Reports (53)
Research institute (2648)
Resumes & cover letters (559)
Rett syndrome (11)
RNA editing (15)
RSV (63)
Schizophrenia (116)
Series A (183)
Series B (137)
Service/supplier (20)
Sickle cell disease (74)
Special edition (24)
Spinal muscular atrophy (167)
Sponsored (39)
Startups (4052)
State (2)
Stomach cancer (17)
Supply chain (90)
Tariffs (81)
The Weekly (100)
Vaccines (996)
Venture capital (63)
Weight loss (362)
Women's health (56)
Worklife (21)
Date
Today (122)
Last 7 days (752)
Last 30 days (2552)
Last 365 days (33123)
2025 (22488)
2024 (37260)
2023 (42172)
2022 (53493)
2021 (58212)
2020 (57127)
2019 (50725)
2018 (38630)
2017 (36153)
2016 (36203)
2015 (41661)
2014 (35004)
2013 (32759)
2012 (33030)
2011 (33302)
2010 (32367)
Location
Africa (1126)
Alabama (75)
Alaska (7)
Arizona (251)
Arkansas (14)
Asia (46974)
Australia (8200)
California (8664)
Canada (2647)
China (819)
Colorado (362)
Connecticut (385)
Delaware (230)
Europe (109298)
Florida (1295)
Georgia (294)
Hawaii (3)
Idaho (67)
Illinois (746)
India (42)
Indiana (413)
Iowa (18)
Japan (264)
Kansas (120)
Kentucky (32)
Louisiana (19)
Maine (75)
Maryland (1189)
Massachusetts (6495)
Michigan (278)
Minnesota (526)
Mississippi (4)
Missouri (113)
Montana (32)
Nebraska (25)
Nevada (99)
New Hampshire (74)
New Jersey (2377)
New Mexico (31)
New York (2367)
North Carolina (1308)
North Dakota (10)
Northern California (3895)
Ohio (272)
Oklahoma (18)
Oregon (39)
Pennsylvania (1825)
Puerto Rico (18)
Rhode Island (44)
South America (1506)
South Carolina (45)
South Dakota (1)
Southern California (3303)
Tennessee (141)
Texas (1345)
United States (32055)
Utah (262)
Virginia (228)
Washington D.C. (81)
Washington State (734)
West Virginia (4)
Wisconsin (84)
784,911 Results for "st michael s hospital".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Career Advice
Leadership Lab: 4 Ways Biopharma Leaders Can Prepare for Media Interviews
Media coverage can help biopharma executives connect with, inform and inspire the public. In this column, Kaye/Bassman’s Michael Pietrack and three communications experts share how to make the most of these opportunities.
August 20, 2025
·
6 min read
·
Michael Pietrack
Business
St. Michael’s Hospital Joins the Phase II Trial of LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury
Arch Biopartners Inc. , (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that a research team from St. Michael’s Hospital, a site of Unity Health Toronto, has joined the Phase II trial for LSALT peptide targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI).
April 16, 2024
·
5 min read
Press Releases
ImmunityBio Announces Houston’s Michael E. DeBakey VA Medical Center Is Among the First VA Hospitals to Administer ANKTIVA® to Bladder Cancer Patients
August 12, 2025
·
8 min read
Career Advice
Leadership Lab: 5 Ways Biopharma Execs Can Restore Trust, Retain Talent After Layoffs
In the latest installment of his column, Kaye/Bassman’s Michael Pietrack shares five ways leaders can help their teams after a layoff, from acknowledging emotions to reestablishing culture.
June 25, 2025
·
4 min read
·
Michael Pietrack
Press Releases
Soricimed Biopharma Inc. Strengthens Executive Team with Appointment of Dr. Michael Groaning PhD, as Chief Scientific Officer
September 2, 2025
·
3 min read
Press Releases
Dynamic Growth Leads C2N Diagnostics to Expand St. Louis Headquarters to Meet Global Need for Answers to Alzheimer’s Disease
September 3, 2025
·
5 min read
World’s First Wearable Ultrasound Patch in use for sepsis care at a Toronto Hospital
FloPatch, a wearable ultrasound device, is in use in two critical care units at St. Michael’s Hospital.
June 5, 2024
·
2 min read
Brain Cancer Canada Awards St. Michael’s Hospital $100,000 Grant for Advanced DNA Sequencer Technology
Brain Cancer Canada, the country’s leading charitable organization dedicated to brain cancer research, has announced a $100,000 grant to St. Michael’s Hospital, a site of Unity Health Toronto.
May 31, 2023
·
2 min read
Press Releases
MediWound’s NexoBrid® to be Highlighted in 36 Scientific Presentations at the 21st European Burns Association Congress
September 3, 2025
·
3 min read
Press Releases
Artios Pharma Appoints Michael T. Andriole as CEO and Director to Advance Alnodesertib (ART0380) into Late-stage Development
August 13, 2025
·
5 min read
1 of 78,492
Next
